Assessment of Rosacea Patients' Clinical Trial Experiences
- Conditions
- Rosacea
- Registration Number
- NCT05747391
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Rosacea patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Rosacea patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Patient is at least 18 years of age
- Diagnosis of Rosacea
- Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
- Inability to perform regular electronic reporting
- Women who are pregnant, intend to become pregnant, or are lactating
- Enrolled in another research study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to join in an Rosacea clinical study 3 months Number of Rosacea patients who remain in clinical trial until completion 12 months
- Secondary Outcome Measures
Name Time Method